Chiron Investment Management, LLC Gilead Sciences, Inc. Transaction History

Chiron Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $25,862 - $37,130	415 New	415 $35,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $24.8 Million - $31.8 Million	-395,799 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $13.3 Million - $14.6 Million	-215,466 Reduced 35.25%	395,799 $25.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.96 Million - $2.16 Million	31,300 Added 5.4%	611,265 $38.7 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $1.2 Million - $1.35 Million	19,404 Added 3.46%	579,965 $39.2 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $7 Million - $7.84 Million	-111,895 Reduced 16.64%	560,561 $36.4 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $3.19 Million - $4.17 Million	-52,770 Reduced 7.28%	672,456 $42.1 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $14 Million - $15.5 Million	196,473 Added 37.16%	725,226 $56 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $6.34 Million - $7.39 Million	97,678 Added 22.66%	528,753 $37.5 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $3.63 Million - $4.43 Million	49,840 Added 13.07%	431,075 $32.5 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $5.51 Million - $6.47 Million	77,500 Added 25.52%	381,235 $27.3 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.69 Million - $3.18 Million	37,235 Added 13.97%	303,735 $24.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	80,000 Added 42.9%	266,500 $18.9 Million
Q1 2017 Aug 15, 2017	BUY	N/A	186,500	186,500 $12.7 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.